Literature DB >> 2859605

Evidence that tolerance develops to the anxiolytic effect of diazepam in rats.

D Treit.   

Abstract

The development of tolerance to the anxiolytic effect of diazepam was studied using suppression of defensive burying as an animal model of anxiolytic action. Although tolerance to the suppressive effect of diazepam was not apparent after chronic administration of diazepam when the rats were tested with a low-intensity shock, anxiolytic tolerance was detected under exactly the same drug regimen when the rats were tested with somewhat higher intensity shocks: under the latter conditions, chronically treated rats buried significantly more than acutely treated rats. Furthermore, this tolerance effect did not appear to depend upon the injection environment, the control vehicle, or the strain of rat; under each of these experimental variations rats chronically treated with diazepam buried significantly more than acutely treated rats when they had received a moderately high intensity shock. These results suggested that tolerance to the anxiolytic effects of benzodiazepines may be detectable when the stimuli eliciting anxiety are relatively intense.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859605     DOI: 10.1016/0091-3057(85)90036-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.

Authors:  S E File; P S Mabbutt; P K Hitchcott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Analysis of the role of drug-predictive environmental stimuli in tolerance to the hypothermic effects of the benzodiazepine midazolam.

Authors:  J W Griffiths; A J Goudie
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Blockade of hoarding in rats by diazepam: an analysis of the anxiety and object value hypotheses of hoarding.

Authors:  R K McNamara; I Q Whishaw
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.

Authors:  J J Byrnes; L G Miller; D J Greenblatt; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.

Authors:  P Chopin; M B Assié; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Development of tolerance to anxiolytic effects of chlordiazepoxide in elevated plus-maze test and decrease of GABAA receptors.

Authors:  S Ishihara; M Hiramatsu; T Kameyama; T Nabeshima
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  Learnt tolerance to sedative effects of chlordiazepoxide on self-stimulation performance, but no tolerance to facilitatory effects after 80 days.

Authors:  L J Herberg; A M Montgomery
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Psychopharmacological effects and safety of styryl-2-pyrones and dihydrostyryl-2-pyrones-rich fraction from Polygala sabulosa: absence of withdrawal syndrome and tolerance to anxiolytic-like and anticonvulsant effects.

Authors:  Filipe Silveira Duarte; Marcelo Duzzioni; Rafael Luiz Prim; Alcíbia Maia Cardozo; Claudia Regina Dos Santos; Maria Goretti da Silva; Maria Beatriz Cacese Shiozawa; Beatriz Garcia Mendes; Tiago Tizziani; Inês Maria Costa Brighente; Moacir Geraldo Pizzolatti; Thereza Christina Monteiro de Lima
Journal:  J Pharm Pharmacol       Date:  2018-06-28       Impact factor: 3.765

9.  Heightened aggression after chronic flunitrazepam in male rats: potential links to cortical and caudate-putamen-binding sites.

Authors:  Rosa Maria M de Almeida; Quelin Benini; Juliana S Betat; Débora C Hipólide; Klaus A Miczek; Anders I Svensson
Journal:  Psychopharmacology (Berl)       Date:  2007-12-14       Impact factor: 4.415

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.